Glycolytic metabolism and tumour response to fractionated irradiation

Radiotherapy and Oncology

Volumn 94, Issue 1, 2010, Pages 102-109

  Sattler, Ulrike G A ^a   Meyer, Sandra S ^a   Quennet, Verena ^a   Hoerner, Christian ^a   Knoerzer, Hannah ^a   Fabian, Christian ^a   Yaromina, Ala ^b   Zips, Daniel ^b   Walenta, Stefan ^a   Baumann, Michael ^b,c,d   Mueller Klieser, Wolfgang ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Radiation Oncology ^*

^c Experimental Centre

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Fractionated irradiation; Human head and neck squamous cell carcinomas; Human tumour xenograft; Local tumour control; Metabolic bioluminescence imaging; Tumour glycolysis

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; CD45 ANTIGEN; GLUCOSE; GLUCOSE TRANSPORTER 1; LACTATE DEHYDROGENASE; LACTIC ACID; MESSENGER RNA; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLYCOLYSIS; HEAD AND NECK CARCINOMA; HUMAN; IRRADIATION; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR XENOGRAFT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOSE FRACTIONATION; GLUCOSE; GLYCOLYSIS; HEAD AND NECK NEOPLASMS; HUMANS; LACTIC ACID; MICE; PYRUVIC ACID;

EID: 74549186565     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.11.007     Document Type: Article

References (37)

1. Rajendran J.G., Mankoff D.A., O'Sullivan F., et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 7 (2004) 2245-2252
2. Zu X.L., and Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 3 (2004) 459-465
3. Atsumi T., Chesney J., Metz C., et al. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 20 (2002) 5881-5887
4. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 11 (2004) 891-899
5. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 4 (2002) S62-S67
6. Warburg O. Origin of cancer cells. Science 3191 (1956) 309-314
7. Schwickert G., Walenta S., Sundfor K., Rofstad E.K., and Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 21 (1995) 4757-4759
8. Walenta S., Salameh A., Lyng H., et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 2 (1997) 409-415
9. Brizel D.M., Schroeder T., Scher R.L., et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2 (2001) 349-353
10. Walenta S., Wetterling M., Lehrke M., et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 4 (2000) 916-921
11. Groussard C., Morel I., Chevanne M., et al. Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. J Appl Physiol 1 (2000) 169-175
12. Salahudeen A.K., Clark E.C., and Nath K.A. Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest 6 (1991) 1886-1893
13. Brown J.M., and Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 6 (2004) 437-447
14. Quennet V., Yaromina A., Zips D., et al. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother Oncol 2 (2006) 130-135
15. Yaromina A., Zips D., Thames H.D., et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 2 (2006) 122-129
16. Yaromina A., Krause M., Thames H., et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol 3 (2007) 304-310
17. Yaromina A., Holscher T., Eicheler W., et al. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiother Oncol 2 (2005) 206-212
18. Bayer C., Schilling D., Hoetzel J., et al. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother Oncol 3 (2008) 361-368
19. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 7 (2008) 545-554
20. Mueller-Klieser W., and Walenta S. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 6 (1993) 407-420
21. Sattler U.G., Walenta S., and Mueller-Klieser W. A bioluminescence technique for quantitative and structure-associated imaging of pyruvate. Lab Invest 1 (2007) 84-92
22. Lallemant B., Evrard A., Combescure C., et al. Reference gene selection for head and neck squamous cell carcinoma gene expression studies. BMC Mol Biol 1 (2009) 78
23. Yaromina A., Eckardt A., Zips D., et al. Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies. Radiother Oncol 3 (2009) 460-465
24. Walenta S., Chau T.-V., Schroeder T., et al. Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?. J Cancer Res Clin Oncol 6 (2003) 321-326
25. Walenta S., and Mueller-Klieser W.F. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 3 (2004) 267-274
26. Walenta S., Schroeder T., and Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 16 (2004) 2195-2204
27. Grotius J., Dittfeld C., Huether M., et al. Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro. Int J Radiat Biol 11 (2009) 989-1001
28. Cuezva J.M., Ortega A.D., Willers I., et al. The tumor suppressor function of mitochondria: translation into the clinics. Biochim Biophys Acta (2009)
29. Melkus G., Morchel P., Behr V.C., et al. Short-echo spectroscopic imaging combined with lactate editing in a single scan. NMR Biomed 10 (2008) 1076-1086
30. Brindle K. New approaches for imaging tumour responses to treatment. Nat Rev Cancer 2 (2008) 94-107
31. Plathow C., and Weber W.A. Tumor cell metabolism imaging. J Nucl Med (2008) 43S-63S
32. Laprie A., Pirzkall A., Haas-Kogan D.A., et al. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 1 (2005) 20-31
33. Raizer J.J., Koutcher J.A., Abrey L.E., et al. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J Neurooncol 2 (2005) 173-180
34. Xu M., See S.J., Ng W.H., et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 5 (2005) 919-926
35. DeBerardinis R.J., Sayed N., Ditsworth D., and Thompson C.B. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 1 (2008) 54-61
36. Yaromina A., Quennet V., Zips D., et al. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. Int J Radiat Biol 11 (2009) 972-980
37. Haji-Michael P.G., Ladriere L., Sener A., Vincent J.L., and Malaisse W.J. Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metab Clin Exp 6 (1999) 779-785